Intco Medical Technology Co., Ltd. (SHE:300677)
China · Delayed Price · Currency is CNY 39.35
-0.73 (-1.82%)
At close: Feb 13, 2026
Intco Medical Technology Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | 1,702 | 1,465 | 383 | 629.07 | 7,430 | 7,007 |
Depreciation & Amortization | 857.42 | 857.42 | 723.5 | 629.94 | 368.62 | 140.02 |
Other Amortization | 7.13 | 7.13 | 0.03 | 1.14 | 0.15 | 0.59 |
Loss (Gain) From Sale of Assets | -0.22 | -0.22 | -0.21 | -2.37 | -0.38 | -0.02 |
Asset Writedown & Restructuring Costs | 196.69 | 196.69 | 51.03 | 37.53 | 93.05 | 15.57 |
Loss (Gain) From Sale of Investments | -407.52 | -407.52 | -263.01 | -151.91 | -61.12 | -4.71 |
Other Operating Activities | 270.99 | -103.83 | 26.83 | -198.22 | 96.04 | 300.8 |
Change in Accounts Receivable | -1,103 | -1,103 | -606.63 | 195.71 | 185.55 | -901.6 |
Change in Inventory | -190.52 | -190.52 | -151.44 | 55.29 | -240.93 | -615.62 |
Change in Accounts Payable | 385.37 | 385.37 | 430.85 | -190.87 | -314.25 | 1,812 |
Change in Other Net Operating Assets | 9.63 | 9.63 | 8.15 | 6.01 | 43.38 | 49.84 |
Operating Cash Flow | 1,691 | 1,079 | 502.41 | 1,065 | 8,680 | 8,590 |
Operating Cash Flow Growth | 118.02% | 114.78% | -52.85% | -87.72% | 1.04% | 2505.63% |
Capital Expenditures | -2,713 | -1,789 | -1,439 | -1,715 | -5,444 | -2,900 |
Sale of Property, Plant & Equipment | 5.09 | 2.54 | 16.81 | 67.28 | 5.58 | 0.18 |
Divestitures | - | - | - | - | 4.6 | - |
Sale (Purchase) of Real Estate | - | - | - | - | - | -3 |
Investment in Securities | -3,811 | -2,336 | -2,638 | -297.13 | -2,325 | -1,124 |
Other Investing Activities | 387.96 | 255.13 | 83.86 | 78.45 | 28.48 | 12.63 |
Investing Cash Flow | -6,131 | -3,868 | -3,976 | -1,867 | -7,730 | -4,015 |
Long-Term Debt Issued | - | 14,060 | 7,896 | 1,849 | 560.29 | 418.42 |
Long-Term Debt Repaid | - | -8,014 | -2,312 | -563.75 | -438.03 | -839.97 |
Net Debt Issued (Repaid) | 4,632 | 6,046 | 5,583 | 1,286 | 122.26 | -421.56 |
Issuance of Common Stock | 172.94 | - | - | 66.45 | - | 556.28 |
Repurchase of Common Stock | - | - | - | - | -1.41 | - |
Common Dividends Paid | -436.43 | -338.28 | -184.92 | -457.11 | -1,074 | -162.8 |
Other Financing Activities | -104.19 | -4,283 | -2,389 | -346.04 | 119.95 | 84.22 |
Financing Cash Flow | 4,265 | 1,425 | 3,009 | 549.05 | -833.25 | 56.14 |
Foreign Exchange Rate Adjustments | 77.18 | 59.85 | 67.05 | 271.8 | -41.77 | -292.11 |
Net Cash Flow | -98.71 | -1,304 | -397.43 | 19.69 | 74.8 | 4,340 |
Free Cash Flow | -1,023 | -710.37 | -936.28 | -649.76 | 3,236 | 5,690 |
Free Cash Flow Growth | - | - | - | - | -43.12% | - |
Free Cash Flow Margin | -10.38% | -7.46% | -13.53% | -9.82% | 19.93% | 41.12% |
Free Cash Flow Per Share | -1.61 | -1.10 | -1.42 | -0.98 | 4.79 | 9.18 |
Cash Income Tax Paid | - | -440.36 | -327.53 | -729.81 | -335.24 | 108.07 |
Levered Free Cash Flow | -1,216 | -1,285 | -1,447 | -994.12 | -230.09 | 2,854 |
Unlevered Free Cash Flow | -963.23 | -1,093 | -1,367 | -976.33 | -219.09 | 3,019 |
Change in Working Capital | -936.08 | -936.08 | -418.76 | 120.3 | 753.64 | 1,131 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.